Back to SGMT

UBS Group AG → SGMT

UBS Group AG SGMT Position History

Sagimet Biosciences Inc. • Healthcare

Quarters held
15
Latest value
$3.3M
Q3 2026
Peak value
$3.3M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$1.8M
Q3 2025$227K
Q3 2025$70K
Q4 2025$1M
Q4 2025$146K
Q4 2025$10K
Q1 2026$954K
Q1 2026$574K
Q1 2026$8K
Q2 2026$1.3M
Q2 2026$1.3M
Q2 2026$39
Q2 2026$8K
Q3 2026$1.1M
Q3 2026$3.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3.3M333.5K——
Q3 2026$1.1M107.4K——
Q2 2026$8K1.0K——
Q2 2026$395——
Q2 2026$1.3M165.3K——
Q2 2026$1.3M173.6K——
Q1 2026$8K1.5K——
Q1 2026$574K109.8K——
Q1 2026$954K182.7K——
Q4 2025$10K1.6K——
Q4 2025$146K24.7K——
Q4 2025$1M175.4K——
Q3 2025$70K10.2K——
Q3 2025$227K33.1K——
Q3 2025$1.8M263.5K——

Other funds holding SGMT

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B